CAG-170: Meta-analysis (n=11,115) discovers unknown health signature in the gut

Over 60% of all gut bacteria cannot be cultured in a lab—and that's precisely where a key to your health may lie. A groundbreaking meta-analysis in Cell Host & Microbe analyzed 11,115 gut metagenomes from 39 countries and identified the bacterial genus CAG-170 as the strongest health-associated signature in the human gut—consistent across 13 non-communicable diseases. Healthy people have significantly more of these invisible microbes, and CAG-170 produces essential vitamin B12. What does this mean for your gut health—and what does CAG-170 boost?

What the meta-analysis shows

To understand the significance of this discovery, we need to briefly delve into the methods of microbiome research. A meta-analysis is like a giant puzzle, assembled from thousands of smaller studies to create a large, clear picture. In this case, researchers compiled data from 11,115 human gut metagenomes from 39 countries.

They used a technique called metagenomics. Imagine it like a high-performance scanner in a library that not only reads the titles of the books (bacterial species) but also captures the entire text of all books simultaneously – including those books that we haven't been able to "read" (cultivate in the lab) before.

• Study type: Metagenomics meta-analysis (Evidence Level A).

• Data basis: n=11,115 metagenomes from 39 countries, distributed across 13 different non-communicable diseases (including Crohn's disease, obesity, diabetes).

• Main result 1: The previously almost unknown bacterial genus CAG-170 (family Oscillospiraceae) was identified as the strongest signature for health.

• Main result 2: A total of 317 "uncultured" species were identified that are strongly linked to clinical health conditions.

• Main result 3: Healthy individuals showed a significantly higher alpha diversity (species richness) specifically in these uncultured bacteria.

• Predictive power: The uncultured microbiome alone achieved an AUROC value of 0.728 (median) for predicting diseases – this is almost as accurate as the known, cultivable microbiome.

• Consistency: In 11 of 13 diseases studied, CAG-170 was significantly associated with health – an extremely robust signal.

Mechanism: Why is CAG-170 a health signal?

Why is this particular, unknown bacterium so important? You can think of CAG-170 as a "peacemaker" or "diplomat" in the microbiological-political system of your gut. It seems to play a central role in maintaining the ecological balance and preventing inflammation from developing in the first place.

• Uncultured bacteria: Over 60% of the bacteria in your gut cannot be cultivated in petri dishes because they require extremely specific conditions (e.g., complete absence of oxygen). They have been "invisible" to science until now.

• Network centrality: The CAG-170 acts as a "hub" (node) in the bacterial network. When present, the entire network is more stable and resistant to interference.

• Vitamin B12 production: Genome analyses show that CAG-170 has a particularly high capacity for the biosynthesis of vitamin B12 – a vitamin that is essential for nerve function and blood formation.

• Cross-feeding: It is suspected that CAG-170 produces metabolites that feed other beneficial bacteria (such as butyrate producers).

• Displacement of pathogens: Through its mere presence and dense network, CAG-170 makes it more difficult for disease-causing germs to settle ("colonization resistance").

• Family affiliation: It belongs to the Oscillospiraceae family, which has often been associated with slimness and metabolic health in previous studies.

What weakens CAG-170 – and what does it promote?

Even though we can't yet swallow CAG-170 in capsule form, we know from metagenome data the conditions under which it thrives – and what harms it. Your lifestyle has a direct impact on this invisible ally.

• Fiber deficiency (enemy number 1): Like many beneficial gut bacteria, CAG-170 relies on complex carbohydrates. A "Western diet" (high in sugar, low in fiber) starves it.

• Antibiotics: As a highly specialized bacterium, CAG-170 is sensitive to broad-spectrum antibiotics. Recovery can take a long time.

• Plant diversity (The Promoter): A diverse plant-based diet (30+ different plants per week) strongly correlates with the occurrence of Oscillospiraceae such as CAG-170.

• Fermented foods: Even if they do not directly contain CAG-170, products like kimchi or kefir create the acidic environment that stabilizes "good" networks.

• Polyphenols: Dyes from berries, green tea or dark chocolate act like "fertilizer" for these families of bacteria.

• Stress: Chronic stress alters the intestinal environment in such a way that sensitive "peacekeepers" like CAG-170 can be displaced.

Dosage & Application

Since CAG-170 is an "uncultured" bacterium, there are (currently) no probiotics containing it available for purchase. The strategy, therefore, is: "Gardening instead of replanting." You need to prepare the soil so that your own CAG-170 can grow.

• Prebiotics instead of probiotics: Focus on resistant starch (cold potatoes/rice), inulin (chicory, artichoke) and acacia fiber.

• Daily amount: Aim for 30-40g of fiber per day. Increase the amount slowly to avoid bloating.

• Timing: Include fiber in every meal to ensure a constant supply for your gut bacteria.

• Variety is key: Eat "the rainbow". Different fibers feed different bacteria and strengthen the network in which CAG-170 plays a central role.

• Avoidance: Reduce ultra-processed foods (UPF), as emulsifiers and additives can damage the mucus layer in which these bacteria live.

• Patience: Microbiome changes take time. Expect 4-12 weeks of consistent dietary changes for measurable effects.

For whom is this finding particularly relevant?

The identification of a universal "health signature" is a milestone for personalized medicine, but also for your daily health care.

• People with inflammatory bowel disease (IBD): CAG-170 levels were significantly reduced in Crohn's disease and ulcerative colitis. Increasing these levels could be part of maintaining remission.

• Metabolic patients: A clear negative correlation was also found in obesity and type 2 diabetes – lower CAG-170, more disease.

• For those interested in prevention: Anyone who wants to minimize their risk of chronic diseases should maintain their "CAG-170 status" (indirectly via diversity).

• Biohacker & Self-Optimizer: Maximizing alpha diversity is one of the most effective levers for longevity.

• Following antibiotic therapy: Focusing on the restoration of sensitive "uncultured" species is particularly important here.

Limitations of the meta-analysis

1. Observational: Metagenomic meta-analysis shows strong statistical correlations, but strictly speaking, it does not yet prove causality (cause and effect).

2. CAG-170 uncultured: Since we cannot yet cultivate the bacterium in the laboratory, direct experimental manipulations (e.g., administration to mice) are not yet possible.

3. Geographical imbalance: Despite 39 countries, data from Europe (36%) and North America (29%) are overrepresented, which slightly limits global generalization.

4. Cross-sectional data dominate: Most data are snapshots. Only a few longitudinal cohorts (progress over time) were included.

5. Functional data limited: Statements regarding vitamin B12 production are based on gene predictions, not on direct measurement of vitamin production in the gut.

⚠ Important note:

This information is for general informational purposes only and does not constitute medical advice. CAG-170-related therapies or targeted microbiome interventions are still in the research phase and are not established as clinical treatments. Existing intestinal diseases or chronic conditions should always be diagnosed and treated by qualified medical professionals.

Sources

1. Almeida A et al. (2026). Meta-analysis of the uncultured gut microbiome across 11,115 global metagenomes reveals a candidate signature of health. Cell Host & Microbe ; 29(3):379-392.e5. DOI: 10.1016/j.chom.2026.01.013

2. Manghi P et al. (2025). Meta-analysis of 22,710 human microbiome metagenomes defines the global human microbiome. Nature Communications ; 16:3118. DOI: 10.1038/s41467-025-66888-1

3. Duvallet C et al. (2017). Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nature Communications ; 8:1784. DOI: 10.1038/s41467-017-01973-8